XRCC1 and lung carcinoma: It seemed that the Arg194Trp may be a reliable predictive locus to assess the pharmacogenetics of XRCC1 gene on clinical outcomes of advanced lung cancer patients treated with platinum-based chemotherapy compared with the Arg399Gln based on ORR outcomes.